Zhijian Yu
- Molecular Biology
- Infectious Diseases top 5%
- Molecular Medicine top 2%
- Epidemiology
- Clinical Biochemistry top 2%
- Topics
- Antimicrobial Resistance in Staphylococcus (51 papers)Bacterial biofilms and quorum sensing (37 papers)Antibiotic Resistance in Bacteria (20 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhijian Yu
78 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 103
- Molecular Biology 504
- Infectious Diseases 445
- Molecular Medicine 283
- Epidemiology 213
- Clinical Biochemistry 164
Countries citing papers authored by Zhijian Yu
This map shows the geographic impact of Zhijian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhijian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhijian Yu more than expected).
Fields of papers citing papers by Zhijian Yu
This network shows the impact of papers produced by Zhijian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhijian Yu. The network helps show where Zhijian Yu may publish in the future.
Co-authorship network of co-authors of Zhijian Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Zhijian Yu. A scholar is included among the top collaborators of Zhijian Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhijian Yu. Zhijian Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | A Real-World Study on Safety and Efficacy of TAF Treatment in HBV Patients with High Risk of Osteoporosis or Osteopenia in China. | 1 |
| 4 | 6 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 32 | |
| 8 | 3 | |
| 9 | 11 | |
| 10 | 1 | |
| 11 | 29 | |
| 12 | 36 | |
| 13 | 9 | |
| 14 | 11 | |
| 15 | 13 | |
| 16 | The distribution of virulence factors in Streptococcus agalactiae and its relationship to antimicrobial resistance and MLST. | 2 |
| 17 | 9 | |
| 18 | 11 | |
| 19 | 14 | |
| 20 | 7 |
About Zhijian Yu
Zhijian Yu is a scholar working on Molecular Medicine, Infectious Diseases and Clinical Biochemistry, having authored 82 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (51 papers), Bacterial biofilms and quorum sensing (37 papers) and Antibiotic Resistance in Bacteria (20 papers). The work is most often cited by research in Molecular Medicine (283 citations), Clinical Biochemistry (164 citations) and Infectious Diseases (445 citations). Zhijian Yu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jinxin Zheng, Qiwen Deng, Zhiwei Lin, Di Qu, Xiang Sun, Guangjian Xu, Duoyun Li, Weiming Yao, Junwen Chen and Yongpeng Shang. Their work appears in journals such as PLoS ONE, Scientific Reports and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.